Hjem › Lungesykdommer › Tennessee › Nashville
Kliniske studier for Lungesykdommer i Nashville, TN
10 studier for Lungesykdommer søker deltakere på steder i og rundt Nashville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
RekruttererFase 2
- Premier Research Center, LLC, Hendersonville · 13 mi unna
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RekruttererFase 3
- SCRI Oncology Partners, Nashville
American Lung Association (ALA) Lung Health Cohort
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Vanderbilt University Medical Center, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Sarah Cannon Research Institue, Nashville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RekruttererFase 2
- Vanderbilt University Medical Center, Nashville
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
RekruttererFase 3
- Clinical Trials Center of Middle Tennesee LLC, Franklin · 17 mi unna
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
RekruttererFase 2
- SCRI Oncology Partners, Nashville
Cooperative Assessment of Late Effects for SCD Curative Therapies
RekruttererObservasjonsstudie
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RekruttererFase 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Lungesykdommer-studier i andre byer
- Houston, TX15 studier
- Boston, MA14 studier
- Durham, NC13 studier
- New York City, NY12 studier
- Pittsburgh, PA11 studier
- Miami, FL10 studier
- Dallas, TX10 studier
- Columbus, OH10 studier
- Los Angeles, CA10 studier
- Washington, DC10 studier
- Ann Arbor, MI10 studier
- Birmingham, AL9 studier
Andre studier i Nashville
- Ikke-småcellet lungekreft97 studier
- Brystkreft81 studier
- Metastatisk kreft70 studier
- Kolorektal kreft69 studier
- Kreft (alle typer)65 studier
- Eggstokkreft49 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Plateepitelcancer i hode og hals39 studier
- Pankreaskreft39 studier
- Endometriekreft38 studier
- Melanom33 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.